Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

Accurate diagnosis of hair loss types is crucial for effective treatment.

Long bean leaf juice significantly promotes hair growth.

A dog had a rare skin cyst, known as a dilated pore of Winer, surgically removed from its neck.

Standardized PRP therapy can improve treatment for hair loss.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.

The three adipokines—leptin, adiponectin, and resistin—are present in various cells of normal dog skin.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Sheep with chronic Sarcoptes scabiei dermatitis have altered keratin expression in their skin.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

A woman with a long-term skin condition developed a serious skin cancer that led to her death.

The Pomeranian recovered well after treatment for pneumonia and demodecosis.